These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 17876939)

  • 1. [Non invasive assessment of liver fibrosis: guidelines of the French National Authority for health and comments of the working group "Biological markers of liver fibrosis" of the French Society of Clinical Biology].
    Bartoli M; Boisson RC; Chevenne F; Gelineau MC; Guéchot J; Guerber F; Lavoinne A; Lasnier E; Mansonneuve L; Myara A; Poggi B; Renversez JC; Rosenthal-Allieri A; Vassault A; Vaubourdolle M;
    Ann Biol Clin (Paris); 2007; 65(4):449-52. PubMed ID: 17876939
    [No Abstract]   [Full Text] [Related]  

  • 2. [Assessment of hepatic fibrosis: what is the role of non-invasive markers in 2003?].
    Mallat A; Dhumeaux D
    Gastroenterol Clin Biol; 2003 Apr; 27(4):367-70. PubMed ID: 12759674
    [No Abstract]   [Full Text] [Related]  

  • 3. Non-invasive diagnosis and monitoring of liver fibrosis and cirrhosis.
    Denzer UW; Lüth S
    Best Pract Res Clin Gastroenterol; 2009; 23(3):453-60. PubMed ID: 19505671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of hepatitis C: non-invasive fibrosis markers and/or liver biopsy.
    Bedossa P
    Liver Int; 2009 Jan; 29 Suppl 1():19-22. PubMed ID: 19207962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-invasive evaluation of liver fibrosis using transient elastography.
    Castera L; Forns X; Alberti A
    J Hepatol; 2008 May; 48(5):835-47. PubMed ID: 18334275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of liver fibrosis in clinical practice].
    Abenavoli L; Leggio L; Gasbarrini G; Addolorato G
    Recenti Prog Med; 2006 Sep; 97(9):481-5. PubMed ID: 17017301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transient elastography and other noninvasive tests to assess hepatic fibrosis in patients with viral hepatitis.
    Castera L
    J Viral Hepat; 2009 May; 16(5):300-14. PubMed ID: 19254351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of fibrosis in chronic liver diseases.
    Zhou K; Lu LG
    J Dig Dis; 2009 Feb; 10(1):7-14. PubMed ID: 19236541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementing non-invasive markers for liver fibrosis in clinical practice.
    Sebastiani G; Alberti A
    J Hepatol; 2008 May; 48(5):880-1; author reply 881-3. PubMed ID: 18314216
    [No Abstract]   [Full Text] [Related]  

  • 10. Diagnosis and quantitation of fibrosis.
    Manning DS; Afdhal NH
    Gastroenterology; 2008 May; 134(6):1670-81. PubMed ID: 18471546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Non-invasive diagnosis of hepatic fibrosis].
    Lu LG; Zeng MD
    Zhonghua Gan Zang Bing Za Zhi; 2006 Mar; 14(3):210-1. PubMed ID: 16556418
    [No Abstract]   [Full Text] [Related]  

  • 12. Assessment of asymptomatic liver fibrosis in alcoholic patients using fibroscan: prospective comparison with seven non-invasive laboratory tests.
    Nguyen-Khac E; Chatelain D; Tramier B; Decrombecque C; Robert B; Joly JP; Brevet M; Grignon P; Lion S; Le Page L; Dupas JL
    Aliment Pharmacol Ther; 2008 Nov; 28(10):1188-98. PubMed ID: 18705692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Recommendations concerning point-of-care systems. "Point-of-care systems" work group of the French Society of Clinical Biology and National College of Hospital Biochemistry].
    Goudable J; Aulois-Griot M; Billion P; Calestrémé P; Coquelin H; Daunizeau A; Del Corso A; Duchassaing D; Jacob JL; Lafond JL
    Ann Biol Clin (Paris); 1998; 56(1):114-5. PubMed ID: 9754235
    [No Abstract]   [Full Text] [Related]  

  • 14. Predictors of steatohepatitis and advanced fibrosis in non-alcoholic fatty liver disease.
    Pagadala M; Zein CO; McCullough AJ
    Clin Liver Dis; 2009 Nov; 13(4):591-606. PubMed ID: 19818307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of AST to platelet ratio index in the detection of liver fibrosis in patients with recurrent hepatitis C after liver transplantation.
    Toniutto P; Fabris C; Bitetto D; Falleti E; Avellini C; Rossi E; Smirne C; Minisini R; Pirisi M
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1904-8. PubMed ID: 17914968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Syndecan 1 (CD138) serum levels: a novel biomarker in predicting liver fibrosis stage in patients with hepatitis C.
    Zvibel I; Halfon P; Fishman S; Penaranda G; Leshno M; Or AB; Halpern Z; Oren R
    Liver Int; 2009 Feb; 29(2):208-12. PubMed ID: 18694404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-invasive biomarkers of liver fibrosis in liver transplant patients with hepatitis C: can we avoid liver biopsies?
    Berenguer M
    Dig Liver Dis; 2009 Mar; 41(3):226-8. PubMed ID: 19138576
    [No Abstract]   [Full Text] [Related]  

  • 18. New diagnostic method for liver fibrosis and cirrhosis.
    Han KH; Yoon KT
    Intervirology; 2008; 51 Suppl 1():11-6. PubMed ID: 18544943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of noninvasive markers for liver fibrosis is reduced in chronic hepatitis C with normal transaminases.
    Sebastiani G; Vario A; Guido M; Alberti A
    J Viral Hepat; 2008 Mar; 15(3):212-8. PubMed ID: 18179453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of non-invasive liver fibrosis biomarkers in HIV/HCV co-infected patients: the fibrovic study--ANRS HC02.
    Cacoub P; Carrat F; Bédossa P; Lambert J; Pénaranda G; Perronne C; Pol S; Halfon P
    J Hepatol; 2008 May; 48(5):765-73. PubMed ID: 18314219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.